388 related articles for article (PubMed ID: 19454440)
1. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():150-3. PubMed ID: 19454440
[No Abstract] [Full Text] [Related]
2. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Oberg K; Akerström G; Rindi G; Jelic S;
Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
[No Abstract] [Full Text] [Related]
4. Neuroendocrine tumour management: a team approach.
Banfield A; Green S; Ramage JK
Hosp Med; 2005 Jan; 66(1):37-42. PubMed ID: 15686165
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
6. Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Grimaldi F; Fazio N; Attanasio R; Frasoldati A; Papini E; Angelini F; Baldelli R; Berretti D; Bianchetti S; Bizzarri G; Caputo M; Castello R; Cremonini N; Crescenzi A; Davì MV; D'Elia AV; Faggiano A; Pizzolitto S; Versari A; Zini M; Rindi G; Oberg K
J Endocrinol Invest; 2014 Sep; 37(9):875-909. PubMed ID: 25038902
[No Abstract] [Full Text] [Related]
7. [Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].
Grabowski P; Hörsch D
Z Gastroenterol; 2015 Oct; 53(10):1194-200. PubMed ID: 26480056
[TBL] [Abstract][Full Text] [Related]
8. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
Kos-Kudła B;
Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
[No Abstract] [Full Text] [Related]
9. Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Cascinu S; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():37-40. PubMed ID: 19454458
[No Abstract] [Full Text] [Related]
10. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
11. [Neuroendocrine tumors of the gastroenteropancreatic system. An interdisciplinary challenge].
Beuschlein F; Reincke M
Internist (Berl); 2012 Feb; 53(2):129-30. PubMed ID: 22457878
[No Abstract] [Full Text] [Related]
12. [More attention should be paid to the understanding of gastroenteropancreatic neuroendocrine tumors].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):158-60. PubMed ID: 22780939
[No Abstract] [Full Text] [Related]
13. Management of neuroendocrine tumors: a meeting of experts from Latin America.
Costa F; Domenichini E; Garavito G; Medrano R; Mendez G; O'Connor J; Rojas W; Torres S; Younes RN; Delle Fave G; Oberg K
Neuroendocrinology; 2008; 88(3):235-42. PubMed ID: 18663282
[TBL] [Abstract][Full Text] [Related]
14. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():147-9. PubMed ID: 19454438
[No Abstract] [Full Text] [Related]
16. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
[No Abstract] [Full Text] [Related]
17. [Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].
Kos-Kudła B; Bolanowski M; Handkiewicz-Junak D; Jarzab B; Królicki L; Krzakowski M; Kunikowska J; Nasierowska-Guttmejer A; Nowak A; Rydzewska G; Starzyńska T; Szawłowski A;
Endokrynol Pol; 2008; 59(1):41-56. PubMed ID: 18335400
[TBL] [Abstract][Full Text] [Related]
18. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
González-Flores E; Serrano R; Sevilla I; Viúdez A; Barriuso J; Benavent M; Capdevila J; Jimenez-Fonseca P; López C; Garcia-Carbonero R
Clin Transl Oncol; 2019 Jan; 21(1):55-63. PubMed ID: 30535553
[TBL] [Abstract][Full Text] [Related]
19. [Standardization in diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms: the Chinese consensus].
Chinese pathologic consensus group for gastrointestinal and pancreatic neuroendocrine neoplasms
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):691-4. PubMed ID: 24439254
[No Abstract] [Full Text] [Related]
20. Current Concepts in the Management of GEP-NETs: Introduction.
Iyer R
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
